GE Healthcare Introduces Biacore™ X100 2.0 and Biacore X100 Plus Package 2.0

Label-free molecular interaction analysis system for the research environment with greater flexibility and sensitivity, and added functionality GE Healthcare announces the launch of Biacore™ X100 2.0 and Biacore X100 Plus Package 2.0, adding new and enhanced functionalities to the versatile, automated real-time molecular interaction analysis system. Single-cycle kinetics is now the preferred method for kinetic [...]

PROdesign GmbH Launches PROcellcare®

Heiligkreuzsteinach / Heidelberg, Germany - PROdesign GmbH launches the innovative cell feeding station PROcellcare® based on a 96 well plate. The System has initially been developed by the licensing partner EMBL (European Molecular Biology Laboratory). PROcellcare® stands for a system, which supplies live cells (in vitro) under the microscope with biological nutrient and working solutions [...]

New testing option extends scope of food safety screening

FOSS has extended the availability of software functionality that helps to spot adulterated raw milk. The software allows MilkoScan™ analysers based on Fourier Transform Infrared (FTIR) technology to be programmed to give a warning of possible abnormalities in raw milk samples. MilkoScan instruments are already used around the world to check raw milk for payment [...]

Cyntellect Launches Stem Cell Manager™ Powered by LEAP™

New Application Offers Significant Improvements Over Manual and Enzymatic Methods for Managing Key Stem Cell Research Processes - World Stem Cell Congress SAN DIEGO--Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, announced today the commercial availability of Stem Cell Manager™ powered [...]

BioCision Inks Distribution Deal with Therapak for Clinical Market

Agreement Expands BioCision’s Reach Into U.S., European Clinical Settings MILL VALLEY, Calif.--BioCision LLC, the CoolRack™ company, today announced that it has entered into an agreement with Therapak Corporation for the distribution of BioCision’s products into the clinical market. The deal marks BioCision’s first distribution agreement for the clinical market and expands its access to clinical [...]

Lab ArmorTM Introduces NEW Bath ArmorTM Beads

Don't Grow Mold in Your Water Bath! Lab ArmorTM has introduced their NEW Bath ArmorTM Beads. The eco-friendly and low-maintenance metallic beads that replace water in water baths, aluminum blocks in dry baths and even ice in ice buckets. Bath Armor Beads are ideal for laboratory use because they eliminate the need for water and [...]

Helicos BioSciences Corporation Announces Pricing of Common Stock and Warrant Private Placement

CAMBRIDGE, Mass.--Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets, today announced that it has entered into a definitive agreement with certain new and existing investors, including Atlas Ventures, Flagship Ventures, Highland Capital Partners, Versant Ventures (the “Existing Investors”) and Ron [...]

New HORIBA Facility in Paris (France)

In September, HORIBA will enter into the purchase agreement of the land for construction of a new research facility on the Campus of Ecole Polytechnique as part of the PARIS Saclay cluster. The new facility will welcome the headquarter of the recently created holding for all HORIBA activities in Europe, HORIBA Europe Holding SAS, consolidating [...]

Northrop Grumman Signs License Agreement for Chemical and Biological Detection Technology

LINTHICUM, Md. -- Northrop Grumman Corporation (NYSE:NOC) and Syagen Technology have signed a product development and license agreement to further strengthen their collaboration in the development of the next generation of chemical biological mass spectrometry instrumentation. The multi-year agreement, funded by Northrop Grumman, will focus on the development of chemical and biological detection using mass [...]

Northrop Grumman Signs License Agreement for Chemical and Biological Detection Technology

LINTHICUM, Md. -- Northrop Grumman Corporation (NYSE:NOC) and Syagen Technology have signed a product development and license agreement to further strengthen their collaboration in the development of the next generation of chemical biological mass spectrometry instrumentation. The multi-year agreement, funded by Northrop Grumman, will focus on the development of chemical and biological detection using mass [...]

Access IBO on Knowledge Center